Would you consider treating the regional nodes in addition to the breast in a patient with skin involvement (pT4b) after a lumpectomy with negative margins/nodes who refuses chemotherapy?   

Would a limited axillary dissection influence your decision? Any other risk factors that would sway your decision?



Answer from: Radiation Oncologist at Community Practice

Answer from: Radiation Oncologist at Academic Institution